BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strickaert A, Saiselet M, Dom G, De Deken X, Dumont JE, Feron O, Sonveaux P, Maenhaut C. Cancer heterogeneity is not compatible with one unique cancer cell metabolic map. Oncogene 2017;36:2637-42. [PMID: 27797377 DOI: 10.1038/onc.2016.411] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Park JK, Coffey NJ, Limoges A, Le A. The Heterogeneity of Lipid Metabolism in Cancer. In: Le A, editor. The Heterogeneity of Cancer Metabolism. Cham: Springer International Publishing; 2018. pp. 33-55. [DOI: 10.1007/978-3-319-77736-8_3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
2 Kareliotis G, Papachristou M, Priftakis D, Datseris I, Makropoulou M. Computational study of necrotic areas in rat liver tissue treated with photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology 2019;192:40-8. [DOI: 10.1016/j.jphotobiol.2019.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer 2017;3:169-80. [PMID: 28393116 DOI: 10.1016/j.trecan.2017.01.005] [Cited by in Crossref: 190] [Cited by in F6Publishing: 182] [Article Influence: 47.5] [Reference Citation Analysis]
4 Cutruzzolà F, Giardina G, Marani M, Macone A, Paiardini A, Rinaldo S, Paone A. Glucose Metabolism in the Progression of Prostate Cancer. Front Physiol 2017;8:97. [PMID: 28270771 DOI: 10.3389/fphys.2017.00097] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
5 Morrow D, Minami J, Nathanson DA. Metabolic Vulnerabilities in Brain Cancer. Neurosurg Clin N Am 2021;32:159-69. [PMID: 33781499 DOI: 10.1016/j.nec.2020.12.006] [Reference Citation Analysis]
6 Becker HM, Deitmer JW. Proton Transport in Cancer Cells: The Role of Carbonic Anhydrases. Int J Mol Sci 2021;22:3171. [PMID: 33804674 DOI: 10.3390/ijms22063171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt SM. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell 2021;56:1363-93. [PMID: 33945792 DOI: 10.1016/j.devcel.2021.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Alvarez R, Mandal D, Chittiboina P. Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors. Cells 2021;10:2913. [PMID: 34831136 DOI: 10.3390/cells10112913] [Reference Citation Analysis]
9 Wang Z, Dong C. Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase. Trends Cancer 2019;5:30-45. [PMID: 30616754 DOI: 10.1016/j.trecan.2018.11.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 14.5] [Reference Citation Analysis]
10 Strickaert A, Corbet C, Spinette S, Craciun L, Dom G, Andry G, Larsimont D, Wattiez R, Dumont JE, Feron O, Maenhaut C. Reprogramming of Energy Metabolism: Increased Expression and Roles of Pyruvate Carboxylase in Papillary Thyroid Cancer. Thyroid 2019;29:845-57. [DOI: 10.1089/thy.2018.0435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
11 Reiter RJ, Sharma R, Ma Q, Rorsales-Corral S, de Almeida Chuffa LG. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis. Cell Mol Life Sci 2020;77:2527-42. [PMID: 31970423 DOI: 10.1007/s00018-019-03438-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
12 Patra S, Elahi N, Armorer A, Arunachalam S, Omala J, Hamid I, Ashton AW, Joyce D, Jiao X, Pestell RG. Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors. Front Oncol 2021;11:700629. [PMID: 34631530 DOI: 10.3389/fonc.2021.700629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tarabichi M, Demetter P, Craciun L, Maenhaut C, Detours V. Thyroid cancer under the scope of emerging technologies. Mol Cell Endocrinol 2021;541:111491. [PMID: 34740746 DOI: 10.1016/j.mce.2021.111491] [Reference Citation Analysis]
14 Horchani M, Della Sala G, Caso A, D'Aria F, Esposito G, Laurenzana I, Giancola C, Costantino V, Jannet HB, Romdhane A. Molecular Docking and Biophysical Studies for Antiproliferative Assessment of Synthetic Pyrazolo-Pyrimidinones Tethered with Hydrazide-Hydrazones. Int J Mol Sci 2021;22:2742. [PMID: 33800505 DOI: 10.3390/ijms22052742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Monteiro F, Hubmann G, Takhaveev V, Vedelaar SR, Norder J, Hekelaar J, Saldida J, Litsios A, Wijma HJ, Schmidt A, Heinemann M. Measuring glycolytic flux in single yeast cells with an orthogonal synthetic biosensor. Mol Syst Biol 2019;15:e9071. [PMID: 31885198 DOI: 10.15252/msb.20199071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
16 Duraj T, Carrión-Navarro J, Seyfried TN, García-Romero N, Ayuso-Sacido A. Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle. Mol Metab 2021;:101389. [PMID: 34749013 DOI: 10.1016/j.molmet.2021.101389] [Reference Citation Analysis]
17 Dang CV. Feeding frenzy for cancer cells. Science 2017;358:862-3. [PMID: 29146793 DOI: 10.1126/science.aaq1070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lappano R, Rigiracciolo DC, Belfiore A, Maggiolini M, De Francesco EM. Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets. Expert Opin Ther Targets 2020;24:559-72. [PMID: 32249708 DOI: 10.1080/14728222.2020.1751819] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
19 Kohrogi K, Hino S, Sakamoto A, Anan K, Takase R, Araki H, Hino Y, Araki K, Sato T, Nakamura K, Nakao M. LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα. Blood Adv 2021;5:2305-18. [PMID: 33929501 DOI: 10.1182/bloodadvances.2020003521] [Reference Citation Analysis]
20 Wong AY, Whited JL. Parallels between wound healing, epimorphic regeneration and solid tumors. Development 2020;147:dev181636. [PMID: 31898582 DOI: 10.1242/dev.181636] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
21 Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Int J Mol Sci 2021;22:5703. [PMID: 34071836 DOI: 10.3390/ijms22115703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Menendez JA, Lupu R. Fatty acid synthase (FASN) as a therapeutic target in breast cancer.Expert Opin Ther Targets. 2017;21:1001-1016. [PMID: 28922023 DOI: 10.1080/14728222.2017.1381087] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 17.4] [Reference Citation Analysis]
23 Kuai XY, Lei ZY, Liu XS, Shao XY. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer. Anticancer Agents Med Chem 2020;20:941-50. [PMID: 32188390 DOI: 10.2174/1871520620666200318094618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Xu L, Chen J, Liu W, Liang C, Hu H, Huang J. Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer. Asian J Urol 2019;6:91-8. [PMID: 30775252 DOI: 10.1016/j.ajur.2018.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Woolbright BL, Ayres M, Taylor JA. Metabolic changes in bladder cancer. Urologic Oncology: Seminars and Original Investigations 2018;36:327-37. [DOI: 10.1016/j.urolonc.2018.04.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
26 Nocquet L, Juin PP, Souazé F. Mitochondria at Center of Exchanges between Cancer Cells and Cancer-Associated Fibroblasts during Tumor Progression. Cancers (Basel) 2020;12:E3017. [PMID: 33080792 DOI: 10.3390/cancers12103017] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Varghese E, Samuel SM, Líšková A, Samec M, Kubatka P, Büsselberg D. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer. Cancers (Basel) 2020;12:E2252. [PMID: 32806533 DOI: 10.3390/cancers12082252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
28 Thabault L, Brisson L, Brustenga C, Martinez Gache SA, Prévost JRC, Kozlova A, Spillier Q, Liberelle M, Benyahia Z, Messens J, Copetti T, Sonveaux P, Frédérick R. Interrogating the Lactate Dehydrogenase Tetramerization Site Using (Stapled) Peptides. J Med Chem 2020;63:4628-43. [PMID: 32250117 DOI: 10.1021/acs.jmedchem.9b01955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Iourov IY, Vorsanova SG, Yurov YB, Kutsev SI. Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism. Genes (Basel) 2019;10:E379. [PMID: 31109140 DOI: 10.3390/genes10050379] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
30 Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer 2018;18:707-19. [PMID: 30327499 DOI: 10.1038/s41568-018-0061-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 41.3] [Reference Citation Analysis]
31 Pappa KI, Daskalakis G, Anagnou NP. Metabolic rewiring is associated with HPV-specific profiles in cervical cancer cell lines. Sci Rep 2021;11:17718. [PMID: 34489482 DOI: 10.1038/s41598-021-96038-8] [Reference Citation Analysis]
32 Grasso D, Zampieri LX, Capelôa T, Van de Velde JA, Sonveaux P. Mitochondria in cancer. Cell Stress 2020;4:114-46. [PMID: 32548570 DOI: 10.15698/cst2020.06.221] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
33 Wolpaw AJ, Dang CV. Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy. Trends Cell Biol 2018;28:201-12. [PMID: 29229182 DOI: 10.1016/j.tcb.2017.11.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 10.6] [Reference Citation Analysis]
34 Jacquet P, Stéphanou A. Metabolic Reprogramming, Questioning, and Implications for Cancer. Biology (Basel) 2021;10:129. [PMID: 33562201 DOI: 10.3390/biology10020129] [Reference Citation Analysis]
35 Strickland M, Stoll EA. Metabolic Reprogramming in Glioma. Front Cell Dev Biol 2017;5:43. [PMID: 28491867 DOI: 10.3389/fcell.2017.00043] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 23.0] [Reference Citation Analysis]
36 Høgset H, Horgan CC, Armstrong JPK, Bergholt MS, Torraca V, Chen Q, Keane TJ, Bugeon L, Dallman MJ, Mostowy S, Stevens MM. In vivo biomolecular imaging of zebrafish embryos using confocal Raman spectroscopy. Nat Commun 2020;11:6172. [PMID: 33268772 DOI: 10.1038/s41467-020-19827-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
37 Podsednik A, Jiang J, Jacob A, Li LZ, Xu HN. Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells. Int J Mol Sci 2021;22:5563. [PMID: 34070254 DOI: 10.3390/ijms22115563] [Reference Citation Analysis]
38 Berndt N, Eckstein J, Heucke N, Wuensch T, Gajowski R, Stockmann M, Meierhofer D, Holzhütter HG. Metabolic heterogeneity of human hepatocellular carcinoma: implications for personalized pharmacological treatment.FEBS J. 2021;288:2332-2346. [PMID: 33030799 DOI: 10.1111/febs.15587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Silva C, Correia-Branco A, Andrade N, Ferreira AC, Soares ML, Sonveaux P, Stephenne J, Martel F. Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines. Eur J Pharmacol 2019;859:172533. [PMID: 31301308 DOI: 10.1016/j.ejphar.2019.172533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
40 Park JK, Coffey NJ, Limoges A, Le A. The Heterogeneity of Lipid Metabolism in Cancer. Adv Exp Med Biol 2021;1311:39-56. [PMID: 34014533 DOI: 10.1007/978-3-030-65768-0_3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
41 Kar M, Sultania M, Roy S, Padhi S, Banerjee B. 𝛽-Catenin-a Possible Prognostic Molecular Marker for Recurrence in Histopathologically Negative Surgical Margin of Oral Cancer. Indian J Surg Oncol 2021;12:128-33. [PMID: 33994738 DOI: 10.1007/s13193-020-01217-0] [Reference Citation Analysis]
42 Atif F, Yousuf S, Espinosa-Garcia C, Sergeeva E, Stein DG. Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma. Sci Rep 2019;9:988. [PMID: 30700763 DOI: 10.1038/s41598-018-37399-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
43 Pfohl U, Pflaume A, Regenbrecht M, Finkler S, Graf Adelmann Q, Reinhard C, Regenbrecht CRA, Wedeken L. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed. Cells 2021;10:928. [PMID: 33920536 DOI: 10.3390/cells10040928] [Reference Citation Analysis]
44 Yao Z, Zhang Q, Guo F, Guo S, Yang B, Liu B, Li P, Li J, Guan S, Liu X. Long Noncoding RNA PCED1B-AS1 Promotes the Warburg Effect and Tumorigenesis by Upregulating HIF-1α in Glioblastoma. Cell Transplant 2020;29:963689720906777. [PMID: 32326742 DOI: 10.1177/0963689720906777] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
45 Chulpanova DS, Kitaeva KV, Rutland CS, Rizvanov AA, Solovyeva VV. Mouse Tumor Models for Advanced Cancer Immunotherapy. Int J Mol Sci 2020;21:E4118. [PMID: 32526987 DOI: 10.3390/ijms21114118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
46 Marchetti P, Trinh A, Khamari R, Kluza J. Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors. Biochim Biophys Acta Gen Subj 2018;1862:999-1005. [PMID: 29413908 DOI: 10.1016/j.bbagen.2018.01.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
47 Logotheti S, Marquardt S, Gupta SK, Richter C, Edelhäuser BAH, Engelmann D, Brenmoehl J, Söhnchen C, Murr N, Alpers M, Singh KP, Wolkenhauer O, Heckl D, Spitschak A, Pützer BM. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1. Theranostics 2020;10:9620-43. [PMID: 32863950 DOI: 10.7150/thno.44176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
48 Morrot A, da Fonseca LM, Salustiano EJ, Gentile LB, Conde L, Filardy AA, Franklim TN, da Costa KM, Freire-de-Lima CG, Freire-de-Lima L. Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses. Front Oncol 2018;8:81. [PMID: 29629338 DOI: 10.3389/fonc.2018.00081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
49 Yu L, Li K, Xu Z, Cui G, Zhang X. Integrated omics and gene expression analysis identifies the loss of metabolite-metabolite correlations in small cell lung cancer. Onco Targets Ther 2018;11:3919-29. [PMID: 30013371 DOI: 10.2147/OTT.S166149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]